Detalles de la búsqueda
1.
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma.
Haematologica
; 105(3): e116-e120, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31320555
2.
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.
Cells
; 10(3)2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33806619
3.
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma.
Cancers (Basel)
; 12(10)2020 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32987735
4.
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma.
Cells
; 8(11)2019 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31766279
5.
The Novel Pan-PIM Kinase Inhibitor, PIM447, Displays Dual Antimyeloma and Bone-Protective Effects, and Potently Synergizes with Current Standards of Care.
Clin Cancer Res
; 23(1): 225-238, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27440267
Resultados
1 -
5
de 5
1
Próxima >
>>